ClinicalTrials.gg
RecruitingNCT07652944Updated Jun 17, 2026

Trial to Test the Efficacy of Using Magnetic Fields to Stimulate the Back to Treat Chronic Lower Back Pain.

An interventional study of peripheral magnetic stimulation and Home exercise in Lower Back Pain Chronic, sponsored by Joe X. Zhang. Recruiting at 1 site in United States. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-06-17.

Sponsored by Joe X. Zhang · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 712 studies in Low Back Pain with a site in United States — 100 open to participants now, 126 under way, 3 of them phase 3. Low Back Pain · United States.

Planned enrollment
295th of 623
88 · median 79
Started
2026
with 32 others
No phase
408 of 712
62 open now
Primary completion
2026-11
later than 34 of 125 live
Registered
697th of 712
by date

Among the 712 studies in Low Back Pain with a site in United States, this one is the 295th largest by planned enrollment of the 623 interventional ones that give a count, is one of 33 that started in 2026, is one of 408 with no phase, reaches primary completion later than 34 of the 125 other live ones, and was the 697th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

100 of the 712 studies in Low Back Pain with a site in United States are open now. Recruiting first, the newest first:

94 more — sign in →

All 100 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 64 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 712 studies in Low Back Pain with a site in United States, or all of them as a file.
02

Study summary

The goal of this study is to see if a new way to treat back pain without the use of medications is effective. We plan use Transcranial Magnetic Stimulation (TMS), a wand-like device, to excite the nerves of people with lower back pain to see if we can decrease pain and improve quality of life.

This study will have two groups and randomly assign participants to a group. One group will have their back nerves stimulated with the TMS device and the other group will not.

Participants will also need to do back exercises at home once a day, and complete questionnaires at each visit before and after each treatment. The total time commitment will be 5 to10 visits with one visit occurring each weekday and each visit lasting up to 30 minutes.

Read the detailed description

The purpose of this research study is to learn about magnetic nerve stimulation and if it can help treat back pain. We believe that magnetic nerve stimulation may improve pain symptoms. Nerve stimulation using electricity and needles is a relatively common medical procedure. This study will use magnetic fields to stimulate nerves to see if it has the same or better effect at decreasing back pain than just doing light workouts. This treatment has been used to treat back pain in the past but the frequency level we are testing has not been well-studied before. This means that the HiVE treatment protocol is still considered to be experimental for the treatment of lower back pain.

Participation in this study will include 5-10 visits one visit per day on weekdays with each session lasting up to 30 minutes and will include TMS treatment (2-3 minutes) and completion of questionnaires (12-30 minutes) before and after treatment. Individuals in the sham group will be offered open label trail of the actual stimulation if the participants desires.

There will be 88 people taking part in the study over a period of 6 months and the overall pain scores as well as a functional activity score will be used to determine effectiveness between treatment and sham groups.

03

Conditions studied

  • Lower Back Pain Chronic

Browse trials for

Keywords

  • magnetic stimulation
  • lower back pain
  • rPMS
  • HiVE
  • repetitive peripheral magnetic stimulation
04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with chronic low back pain (greater than or equal to 12 weeks) with or without concurrent neck pain.
  • Low back pain in the paraspinal region (L1-S2) by asking the patient to point to their area of pain.
  • 18 - 64 years old (on the day of )
  • Willing and able to attend all study visits.
  • No medication changes for at least 30 days before study enrollment (self-report)
  • Eligible for care at participating military treatment facilities
  • Able to read and understand English.
  • Negative pregnancy test for women capable of pregnancy.

Exclusion criteria

Exclusion Criteria:

  • Diagnosed with low back pain of less than 12 weeks duration
  • History of back fractures or surgical repair of the back
  • History of depression with vagus nerve stimulation
  • Any type of transcranial magnetic stimulation (TMS), or rPMS treatment prior to study enrollment.
  • Currently using any other adjunctive treatments for chronic back pain such as low-level laser treatment, ultrasound, dry needling, chiropractor manipulations, cervical collars, TENS units, or other stimulation, eastern medicine regimens including Qi Gong or Tai Chi. (Exception: strength building physical therapy, non-neuropathic pain modifiers, and non-anticonvulsant routine pain medicine regimens such as NSAIDS and Acetaminophen are allowed).Scheduled for nerve ablation, dry needling, trigger point injections, nerve block, therapeutic ultrasound, other stimulation, or similar adjunct treatments during the study period.
  • Diagnosed with a specific low back pain: osteoarthritis, rheumatoid arthritis, phantom limb pain, central pain syndrome, spinal cord damage, myofascial pain syndrome, or other more specific diagnosis (at investigators discretion).
  • Unstable or poorly controlled mental health diagnosis (e.g., current changes in medication or medical management).
  • Dermal or subdermal implants (e.g., aneurysm clips, shunts, stimulators, ferro magnetic implants, stents, or electrodes, or pacemakers) or any other metal object within or near the site of stimulation which cannot be safely removed.
  • abnormality or clinically significant unstable medical condition that, in the investigator's judgment, might pose a potential safety risk to the subject or limit interpretation of the trial results.
  • Any condition which, in the judgment of the investigator, would prevent the patient from completing study procedures.
  • Pregnancy
  • Younger than 18 years old (on the day of )
  • Older than 64 years old (on the day of informed consent)
  • NOT willing or able to attend all study visits.
  • Medication changes for back pain less than 30 days prior to study enrollment (self-report)
  • NOT eligible for care at participating military treatment facilities
  • NOT able to read and understand English.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
88 participants (estimated)

Study arms

  • Experimental
    Treatment Arm

    Individuals in this arm receive magnetic stimulation to the area of the lower back where they have pain from sessions 1 through 5. We begin stimulation operation at 20% advancing in 5% increments to maximum of 35% machine power which in our case is approximately 0.3 tesla to 0.58 tesla of power (a typical outpatient MRI is 1.5 to 3 tesla). The power of the unit will be titrated up to the maximum 35% based on patient tolerance by asking participants to "Tell me if you feel a painful muscle contraction". Patients receiving active therapy would be able to feel the stimulus usually described as a vibration sensation. If patients report painful muscle contractions, stop and go back by 5%. Doing this helps ensure that we would not cause any potentially painful muscle contractions and avoid confounding our test data. The first treatment will start at 20% power then increase by 5% until the titrated power level is identified, subsequent treatments will start at the power level last used.

    Device: peripheral magnetic stimulation · Behavioral: Home exercise

  • Sham comparator
    Sham Arm

    The investigators will configure the rPMS device to not utilize any power, then place the treatment wand over the participant's back pain area and hit the start button like they do in the treatment arm. When the power setting is set to zero, the magnetic wand will not generate any power but will still make the customary computer-generated tones as it does in normal operation. The device is set to play a completed tone once 2 minutes and 30 seconds have elapsed just as it does in the normal treatment. The investigator will then replace the wand back to the storage position and notify the patient that the session is completed. Following completion of 5 sessions, the sham group will be offered to receive up to 5 sessions of real rPMS stimulation. The data from the sham treatment and real rPMS treatment for these patients will be tracked separately.

    Behavioral: Home exercise

Interventions

  • Deviceperipheral magnetic stimulation

    Our stimulation protocol is ssing approximately 0.3 tesla to 0.58 tesla of magnetic power using a variable stimulation frequency between 11ms and 14ms with center value of 13ms between pulses. This translates to estimated values of lower bounds of 71.43 Hz, central value of 83 Hz, and maximum value of 99 Hz .

    Also known as: magnetic stimulation, rPMS, repetitive magnetic stimulation, repetitive peripheral magnetic stimulation

  • BehavioralHome exercise

    All patients will receive a home exercise guide and recommended to perform the stated number of repetitions of those exercises. Exercises include Neutral Curl Up with Straight Leg, Plank on Elbow, and Bird Dog positions.

    Also known as: back pain exercises, home physical therapy, Neutral Curl Up with Straight Leg, Plank on Elbow, Bird Dog

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale

    Visual Analog Scale or VAS is a common self reported pain measurement scale from 0 - 100 with 0 being pain free and 100 being most pain possible.

    Time frame: VAS numbers are obtained at: Baseline, pre-intervention. Immediately before each intervention Immediately after each intervention

Secondary outcomes

  1. ODI

    Oswestry Disability Index (ODI) is a set of questions used to identify participant's functional status as related to activities of daily living.

    Time frame: Scores are obtained at: Baseline, pre-intervention. Immediately after intervention session 2 Immediately after intervention session 5 Immediately after intervention session 10 for those that elect to opt in for open label portion of study

07

Study locations

1 of 1 sites recruiting
  • 412 Medical Group
    Edwards Air Force Base, California 93524, United States
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — measured variables such as VAS and ODI scales for the study along with power tolerated by de-identified individuals using participant ID only can be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: Will be available at the conclusion of data collection (estimated Nov 2026) and be available for up to 2 years (Nov 2028)

Access criteria: De-identified data can be made available upon request. Data is stored on secured government systems and cannot be actively reviewed without permission and assistance from investigation team. A formal request needs to be coordinated with the research team to be able to gain access to the data sheets.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Nov 2026, 4 months later.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 4 months is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
May 27, 2026
First posted
Jun 17, 2026
StartEst.
Jul 2026
Primary completionEst.
Nov 2026
CompletionEst.
Feb 2027
Last update
Jun 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07652944
Lead sponsor
Joe X. Zhang
Responsible party
Joe X. Zhang (Commander, Madigan Army Medical Center) — Sponsor-investigator
First posted
Jun 17, 2026
Start date
Jul 2026 (estimated)
Primary completion
Nov 2026 (estimated)
Completion
Feb 2027 (estimated)
Last update
Jun 17, 2026

Study contacts

Joe Zhang, MD
Contact
joe.x.zhang.mil@health.mil
415-619-9997
Joshua Ford, PhysD
Contact
joshua.c.ford21.mil@health.mil
661-275-5057
Joe Zhang, MD
study director · United States Air Force

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion